semaglutide compounding pharmacy lawsuit FDA ignites new fight over copycat GLP-1 weight loss drugs An update from hims/hers: Compounded

It addresses the underlying problem causing your hair loss, not just the symptoms

Mounjaro: A New GLP-1 Agonist For Weight Loss and Type 2 Diabetes A breakthrough in diabetes management and weight loss , Mounjaro (tirzepatide) is gaining attention in the role of a dual-action medication

The relationship between GLP-1 use and overall experience is not yet generally understood and is changing as the coverage environment evolves

The precise dose and timing remain under investigation in clinical trials

The number of clusters (k=5) was chosen objectively by maximizing a combined score of: Silhouette coefficient on a discovery split: measures how well-separated the clusters are internally Adjusted Rand Index (ARI) on a held-out validation split: measures whether an independent reclustering of new data produces the same structure This two-stage validation approach guards against over-fitting the cluster count to a single sample